此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Bronchoscopy Study for Severe Asthma

2015年5月28日 更新者:University of Pennsylvania

An Exploratory Study to Obtain Functional and Transcriptional/Translational Profiling of Cells From Bronchial Lavages and Brushings in Severe Asthmatics and Healthy Control Subjects

The purpose of this research study is to collect lung tissue and fluid from two groups of people: those who have severe asthma, and those who do not. These samples will then be tested in a laboratory to identify differences in the lung tissue cells and fluids that may exist between these two groups of people.

研究概览

地位

撤销

研究类型

观察性的

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Pennsylvania
      • Philadelphia、Pennsylvania、美国、19104
        • Airways Biology Initiative at the University of Pennsylvania

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 65年 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

取样方法

非概率样本

研究人群

10 severe asthma subjects matched with 10 healthy control subjects

描述

Inclusion Criteria:

  • Asthma Subject Inclusion Criteria

    1. Subject is an adult male or female between 18 and 65 years of age inclusive.
    2. Subject must have a pre-history of a physician's diagnosis of severe asthma (according to GINA classification) with some reversible airway obstruction (shown by peak flow or FEV1 in the last 12 months with a change of 12% in the absolute FEV1 measurement) and an exclusion of other significant pulmonary diseases (i.e., cystic fibrosis, tuberculosis, Interstitial Lung Disease and bronchopulmonary dysplasia)
    3. Subject has a positive methacholine test (PC20 < 16). This test sometimes cannot be performed in severe asthmatics because of low baseline FEV1 (< FEV1 50%). SABA reversibility of FEV1 is sufficient to define asthma in absence of MCh PC20.
    4. Subject's asthma has been stable for the past 30 days.
    5. The subject has been a non-smoker for the past year and should have less than a 10 pack year history.
    6. The subject must be capable of and willing to provide written informed consent
    7. The subject is able to understand and comply with protocol requirements and timetables, instructions and protocol-stated restrictions.
  • Healthy Subject Inclusion Criteria

    1. Subject is an adult male or female between 18 and 65 years of age inclusive. (Subjects will be age and gender matched) With age matching, we will enroll in a manner that age and gender will be matched 1:1 in the following cohorts: age 21-30, 31-40, 41-50, 51-60, 61-65.
    2. Subject must have an exclusion of asthma or other significant pulmonary diseases (i.e., cystic fibrosis, tuberculosis, Interstitial Lung Disease and bronchopulmonary dysplasia)
    3. The subject has been a non-smoker for the past year and should have less than a 10 pack year history.
    4. The subject has a negative methacholine test (PC20 > 16) and does not use inhaled steroids and/or SABA.
    5. The subject must be capable of and willing to provide written informed consent
    6. The subject is able to understand and comply with protocol requirements and timetables, instructions and protocol-stated restrictions.

      -

      Exclusion Criteria:

    1. As a result of the medical interview, physical examination or screening investigations, the physician responsible considers the volunteer unfit for the study.
    2. The subject has received an investigational drug or participated in any other research trial within 30 days or 5 half-lives, or twice the duration of the biological effect of any drug (whichever is longer), prior to the current study.
    3. No oral steroids within the last 3 months.
    4. No current anticoagulant and/or antiplatelet therapy.
    5. The subject has a history of alcohol or drug abuse within the last 5 years.
    6. The subject has history of hepatitis B, hepatitis C, or HIV virus.
    7. The subject has a history of chemotherapy or radiotherapy within the last 2 years.
    8. The subject has a history of diabetes.
    9. The subject is pregnant or lactating.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

队列和干预

团体/队列
干预/治疗
Severe Asthmatics
Subjects with a pre-existing physician diagnosis of asthma with reversible airflow obstruction of at least 12%.
Subjects will have a screening visit and, if they qualify to take part in the study, they will undergo a single bronchoscopy procedure. During the bronchoscopy, bronchoalveolar lavage (BAL) and bronchial brushings will be performed on each subject.
其他名称:
  • Fiberoptic Bronchoscopy
  • 支气管肺泡灌洗
Healthy non-smokers
Subjects will be never smokers or former smokers for the past year and less than 10 pack years lifetime with no history of asthma or any other lung disease.
Subjects will have a screening visit and, if they qualify to take part in the study, they will undergo a single bronchoscopy procedure. During the bronchoscopy, bronchoalveolar lavage (BAL) and bronchial brushings will be performed on each subject.
其他名称:
  • Fiberoptic Bronchoscopy
  • 支气管肺泡灌洗

研究衡量的是什么?

主要结果指标

结果测量
大体时间
To obtain bronchial brushings and bronchial alveolar lavage fluid from 10 subjects with severe asthma (GINA criteria in The Global Initiative for Asthma, http://www.ginasthma.org ) and from 10 matched normal healthy subjects.
大体时间:1 year
1 year

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

合作者

调查人员

  • 首席研究员:Reynold Panettieri, MD、University of Pennsylvania

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2013年1月1日

初级完成 (预期的)

2014年12月1日

研究完成 (预期的)

2014年12月1日

研究注册日期

首次提交

2012年12月6日

首先提交符合 QC 标准的

2012年12月6日

首次发布 (估计)

2012年12月10日

研究记录更新

最后更新发布 (估计)

2015年6月1日

上次提交的符合 QC 标准的更新

2015年5月28日

最后验证

2011年10月1日

更多信息

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅